Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

NCT02175784 ·Status: COMPLETED ·Phase: PHASE4

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

NCT01225081 ·Status: COMPLETED ·Phase: PHASE3

Actos Now for Prevention of Diabetes (ACT NOW)

NCT00220961 ·Status: COMPLETED ·Phase: PHASE3

Post-Marketing Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of Ipragliflozin in Combination With GLP-1 Receptor Agonists in Japanese Patients With Type 2 Diabetes Mellitus (T2DM)

NCT02291874 ·Status: COMPLETED ·Phase: PHASE4

The Impact of Actos Treatment of Diabetes on Glucose Transporters in Muscle

NCT01799850 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

NCT00772174 ·Status: COMPLETED ·Phase: PHASE3

Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"

NCT02221284 ·Status: COMPLETED

An Observational Study of Patient Cohorts Who Previously Received Long-term Treatment With Pioglitazone or Placebo in Addition to Existing Antidiabetic Medications

NCT02678676 ·Status: COMPLETED

Safety Study of Pioglitazone Compared To Glyburide on Liver Function

NCT00494312 ·Status: COMPLETED ·Phase: PHASE4

Food Study of Pioglitazone HCl Tablets 45 mg to Actos® Tablets 45 mg

NCT00649012 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

NCT00770445 ·Status: COMPLETED ·Phase: PHASE4

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus

NCT00432276 ·Status: COMPLETED ·Phase: PHASE3

Insulin Resistance Intervention After Stroke Trial

NCT00091949 ·Status: COMPLETED ·Phase: PHASE3

Alogliptin/Pioglitazone (Liovel) Combination Tablets Survey on Long-term Use in Patients With Type 2 Diabetes Mellitus

NCT01990300 ·Status: COMPLETED

Efficacy and Safety of Pioglitazone Combination Therapy in Type 2 Diabetes Patients on a Background of Empagliflozin With Metformin

NCT06571591 ·Status: COMPLETED ·Phase: PHASE3

Placebo and Active Controlled Study of Rivoglitazone in Type 2 Diabetes

NCT00143520 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

NCT00991055 ·Status: UNKNOWN ·Phase: PHASE4

Study of Ipragliflozin in Patients With Type 2 Diabetes Mellitus Receiving Insulin Therapy

NCT02847091 ·Status: COMPLETED ·Phase: PHASE4

A Placebo Controlled Safety and Efficacy Study of MSDC-0160 in Type 2 Diabetes With Active Comparator

NCT00760578 ·Status: COMPLETED ·Phase: PHASE2

Specified Drug Use Results Survey of Ipragliflozin Treatment in type2 Diabetes Patients

NCT02479399 ·Status: COMPLETED

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

NCT01280695 ·Status: COMPLETED ·Phase: PHASE2

Efficacy of Pioglitazone/Metformin Combination Therapy in Subjects With Type 2 Diabetes Mellitus and Dyslipidemia.

NCT00770653 ·Status: COMPLETED ·Phase: PHASE3

Efficacy of Pioglitazone and Glimepiride Combination Therapy in Treating Subjects With Type 2 Diabetes Mellitus.

NCT00770952 ·Status: COMPLETED ·Phase: PHASE3

Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

NCT00232362 ·Status: WITHDRAWN ·Phase: PHASE1